The MarketWatch News Department was not involved in the creation of this content. BOSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology ...
In 1986, Peter Drucker warned of a severe threat to our “long-term economic future.” “Corporate managements,” he wrote, “are being pushed into subordinating everything (even such long-range ...
Boston, MA, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Activist investor Strategic EP, LLC has filed a Schedule 13D with the U.S. Securities and Exchange Commission, disclosing a significant ownership position ...
SUMMIT, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced that the Company’s Board of Directors has authorized the initiation of a ...
Intends to Vote Against Every Incumbent Director at 2026 Annual Meeting if the Board Continues to Put Shareholder Value at Risk HOUSTON--(BUSINESS WIRE)-- Bradley L. Radoff, who collectively with his ...
Asserts the Board Should Immediately Announce the Formal Retention of an Investment Bank and Plan to Vigorously Explore Mergers as Rail Consolidation Persists Believes CSX Should be Conducting Ongoing ...
BOSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results